Paradigm (ASX:PAR) share price drops on drug application update
Raymond Jang
April 26, 2021
The share price of Paradigm Biopharmaceuticals Ltd (ASX: PAR) is
Paradigm Biopharmaceuticals Ltd (ASX:PAR) has repurposed an anti-inflammatory drug called pentosan polysulphate sodium (PPS) to treat multiple new indications, including Osteoarthritis.
The share price of Paradigm Biopharmaceuticals Ltd (ASX: PAR) is
Making ASX 200 news today was Paradigm Biopharmaceuticals Ltd (ASX:PAR),
The Paradigm Biopharmaceuticals (ASX: PAR) share price was trading 1.4%
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.